Literature DB >> 19254569

TORC2 regulates hepatic insulin signaling via a mammalian phosphatidic acid phosphatase, LIPIN1.

Dongryeol Ryu1, Kyoung-Jin Oh, Hee-Yeon Jo, Susan Hedrick, Yo-Na Kim, Yu-Jin Hwang, Tae-Sik Park, Joong-Soo Han, Cheol Soo Choi, Marc Montminy, Seung-Hoi Koo.   

Abstract

TORC2 is a major transcriptional coactivator for hepatic glucose production. Insulin impedes gluconeogenesis by inhibiting TORC2 via SIK2-dependent phosphorylation at Ser171. Interruption of this process greatly perturbs hepatic glucose metabolism, thus promoting hyperglycemia in rodents. Here, we show that hyperactivation of TORC2 would exacerbate insulin resistance by enhancing expression of LIPIN1, a mammalian phosphatidic acid phosphatase for diacylglycerol (DAG) synthesis. Diet-induced or genetic obesity increases LIPIN1 expression in mouse liver, and TORC2 is responsible for its transcriptional activation. While overexpression of LIPIN1 disturbs hepatic insulin signaling, knockdown of LIPIN1 ameliorates hyperglycemia and insulin resistance by reducing DAG and PKCvarepsilon activity in db/db mice. Finally, TORC2-mediated insulin resistance is partially rescued by concomitant knockdown of LIPIN1, confirming the critical role of LIPIN1 in the perturbation of hepatic insulin signaling. These data propose that dysregulation of TORC2 would further exaggerate insulin resistance and promote type 2 diabetes in a LIPIN1-dependent manner.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19254569     DOI: 10.1016/j.cmet.2009.01.007

Source DB:  PubMed          Journal:  Cell Metab        ISSN: 1550-4131            Impact factor:   27.287


  52 in total

1.  Liver-specific loss of lipin-1-mediated phosphatidic acid phosphatase activity does not mitigate intrahepatic TG accumulation in mice.

Authors:  George G Schweitzer; Zhouji Chen; Connie Gan; Kyle S McCommis; Nisreen Soufi; Roman Chrast; Mayurranjan S Mitra; Kui Yang; Richard W Gross; Brian N Finck
Journal:  J Lipid Res       Date:  2015-02-26       Impact factor: 5.922

2.  Chronic activation of FXR-induced liver growth with tissue-specific targeting Cyclin D1.

Authors:  Weibin Wu; Qing Wu; Xinmei Liu
Journal:  Cell Cycle       Date:  2019-06-25       Impact factor: 4.534

3.  Suppressor of MEK null (SMEK)/protein phosphatase 4 catalytic subunit (PP4C) is a key regulator of hepatic gluconeogenesis.

Authors:  Young-Sil Yoon; Min-Woo Lee; Dongryeol Ryu; Jeong Ho Kim; Hui Ma; Woo-Young Seo; Yo-Na Kim; Su Sung Kim; Chul Ho Lee; Tony Hunter; Cheol Soo Choi; Marc R Montminy; Seung-Hoi Koo
Journal:  Proc Natl Acad Sci U S A       Date:  2010-09-27       Impact factor: 11.205

4.  Emerging Pharmacological Targets for the Treatment of Nonalcoholic Fatty Liver Disease, Insulin Resistance, and Type 2 Diabetes.

Authors:  Leigh Goedeke; Rachel J Perry; Gerald I Shulman
Journal:  Annu Rev Pharmacol Toxicol       Date:  2019-01-06       Impact factor: 13.820

5.  Lipin-1 expression is critical for keratinocyte differentiation.

Authors:  Minjung Chae; Ji-Yong Jung; Il-Hong Bae; Hyoung-June Kim; Tae Ryong Lee; Dong Wook Shin
Journal:  J Lipid Res       Date:  2015-12-13       Impact factor: 5.922

6.  Expression of the splicing factor gene SFRS10 is reduced in human obesity and contributes to enhanced lipogenesis.

Authors:  Jussi Pihlajamäki; Carles Lerin; Paula Itkonen; Tanner Boes; Thomas Floss; Joshua Schroeder; Farrell Dearie; Sarah Crunkhorn; Furkan Burak; Josep C Jimenez-Chillaron; Tiina Kuulasmaa; Pekka Miettinen; Peter J Park; Imad Nasser; Zhenwen Zhao; Zhaiyi Zhang; Yan Xu; Wolfgang Wurst; Hongmei Ren; Andrew J Morris; Stefan Stamm; Allison B Goldfine; Markku Laakso; Mary Elizabeth Patti
Journal:  Cell Metab       Date:  2011-08-03       Impact factor: 27.287

7.  Glucose-6-phosphate isomerase deficiency results in mTOR activation, failed translocation of lipin 1α to the nucleus and hypersensitivity to glucose: Implications for the inherited glycolytic disease.

Authors:  Jorge F Haller; Sarah A Krawczyk; Lubov Gostilovitch; Barbara E Corkey; Raphael A Zoeller
Journal:  Biochim Biophys Acta       Date:  2011-07-21

Review 8.  Mechanisms of Insulin Action and Insulin Resistance.

Authors:  Max C Petersen; Gerald I Shulman
Journal:  Physiol Rev       Date:  2018-10-01       Impact factor: 37.312

9.  Glucagon-CREB/CRTC2 signaling cascade regulates hepatic BMAL1 protein.

Authors:  Xiujie Sun; Fabin Dang; Deyi Zhang; Yuan Yuan; Cui Zhang; Yuting Wu; Yiguo Wang; Yi Liu
Journal:  J Biol Chem       Date:  2014-12-05       Impact factor: 5.157

10.  Isolation of novel animal cell lines defective in glycerolipid biosynthesis reveals mutations in glucose-6-phosphate isomerase.

Authors:  Jorge F Haller; Conor Smith; Dailan Liu; Hongying Zheng; Keith Tornheim; Gil-Soo Han; George M Carman; Raphael A Zoeller
Journal:  J Biol Chem       Date:  2009-11-10       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.